In a nutshell This trial is examining the effectiveness and safety of 6MPH, a melanoma vaccine with adjuvants and a CDX-1127 monoclonal antibody in patients with melanoma. The main outcomes to be measured will be side effects and the response of the immune system. This trial is recruiting in Virginia, United States. The details A treatment option...
Read MoreCurrent stage-Stage II-II-C Posts on Medivizor
Looking for patients with surgically resected stage II melanoma to test the safety and effectiveness of pembrolizumab
In a nutshell This trial aims to evaluate the safety and effectiveness of pembrolizumab (Keytruda) in stopping cancer coming back, compared to placebo in participants with surgically resected high-risk stage II melanoma. The main outcome that will be measured is how long patients go without cancer coming back (recurrence-free...
Read MoreIs targeted chemotherapy for stage II/III rectal cancer before surgery effective?
In a nutshell This study examined the effect of pre-surgical chemotherapy without radiotherapy in stage II/III rectal cancer. The study showed that combined targeted chemotherapy was effective in these patients. Some background Rectal cancer is a cancer of the end part of the digestive system. In stage II and III, the cancer has begun to...
Read MoreCutting-Edge Research Continues to Bring Personalized Medicine to Melanoma Patients (video)
One out of 10 people will be diagnosed with melanoma over their lifetime. While this used to be a death sentence of only months, research has made great strides over the last decade, extending life and hope by years. Dr. Sapna Patel, assistant professor in the Department of Melanoma Medical Oncology at the University of Texas MD Anderson...
Read MoreConsensus statement from the society for immunotherapy of cancer
In a nutshell This review examines the evidence regarding immunotherapy in the treatment of advanced melanoma. Some background While early detection and surgical treatments have significantly reduced mortality rates for early stage melanoma patients, survival rates for advanced melanoma patients remain relatively low. Recent advances based on...
Read More
